Dow Down 0.25% Nasdaq Down 0.14%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.46 0.04(2.82%) Sep 29, 4:00PM EDT
Prev Close:1.42
Open:1.41
Bid:1.45 x 2000
Ask:1.54 x 1000
1y Target Est:4.50
Beta:3.76
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.40 - 1.52
52wk Range:1.10 - 2.14
Volume:3,302,426
Avg Vol (3m):1,617,950
Market Cap:383.80M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXUp 2.82%383.80M
GSK111.19B
MRK171.38B
RHHBY250.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback